Home » Stocks » Edwards Lifesciences

Edwards Lifesciences Corporation (EW)

Stock Price: $83.88 USD -1.45 (-1.70%)
Updated Oct 19, 2020 3:43 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 52.15B
Revenue (ttm) 4.32B
Net Income (ttm) 743.60M
Shares Out 621.74M
EPS (ttm) 1.18
PE Ratio 71.08
Forward PE 38.61
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 19, 2020
Last Price $83.88
Previous Close $85.33
Change ($) -1.45
Change (%) -1.70%
Day's Open 85.50
Day's Range 83.23 - 86.73
Day's Volume 1,258,349
52-Week Range 51.51 - 87.79

More Stats

Market Cap 52.15B
Enterprise Value 51.67B
Earnings Date (est) Oct 21, 2020
Ex-Dividend Date Jun 1, 2020
Shares Outstanding 621.74M
Float 616.48M
EPS (basic) 1.19
EPS (diluted) 1.18
FCF / Share 1.51
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.41%
FCF Yield 1.80%
Payout Ratio n/a
Shares Short 6.69M
Short Ratio 2.32
Short % of Float 1.09%
Beta 0.90
PE Ratio 71.08
Forward PE 38.61
P/FCF Ratio 55.67
PS Ratio 12.07
PB Ratio 13.82
Revenue 4.32B
Operating Income 790.10M
Net Income 743.60M
Free Cash Flow 936.80M
Net Cash 479.30M
Net Cash / Share 0.77
Gross Margin 74.82%
Operating Margin 18.28%
Profit Margin 17.20%
FCF Margin 21.68%
ROA 12.99%
ROE 20.26%
ROIC 23.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (25)

Buy 13
Overweight 1
Hold 9
Underweight 1
Sell 1

Analyst Consensus: Overweight

Price Target

$86.62*
(3.27% upside)
Low
68.0
Current: $83.88
High
100.0
Target: 86.62
*Average 12-month price target from 20 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue4,3483,7233,4352,9642,4942,3232,0461,9001,6791,447
Revenue Growth16.79%8.37%15.91%18.85%7.35%13.56%7.68%13.17%16.01%-
Gross Profit3,2342,7832,5602,1661,8771,6971,5291,4091,1891,039
Operating Income1,1417501,0297526361,163518390279262
Net Income1,047722584570495811389292237218
Shares Outstanding625628633639647639670689688682
Earnings Per Share1.641.130.900.870.751.250.570.410.330.31
EPS Growth45.79%25.22%3.45%16%-39.86%118.77%39.02%24.24%8.2%-
Operating Cash Flow1,1799271,0017045501,022473362308251
Capital Expenditures-254-239-168-176-103-79.80-107-106-72.70-55.20
Free Cash Flow925688833528447943366256236196
Cash & Equivalents1,5179571,3381,2711,2251,439937521451396
Total Debt6795941,03682259759859318915041.80
Net Cash / Debt838363301449628841344332300354
Assets6,4885,3245,6664,5104,0563,5232,7102,2221,9811,767
Liabilities2,3402,1832,7101,8911,5531,3321,166742643459
Book Value4,1483,1402,9562,6192,5032,1911,5441,4791,3381,308
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Edwards Lifesciences Corporation
Country United States
Employees 13,900
CEO Michael A. Mussallem

Stock Information

Ticker Symbol EW
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: EW
IPO Date March 27, 2000

Description

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.